VXGN just hit target of 11 doing great, while biotechs are awful from last Friday but we haven't had one on the list since the one day GILD was up. Target now raised to 13 or higher.
VaxGen (Nasdaq: VXGN - News) will hold a conference call and webcast Tuesday, February 10, to review financial results from its fourth quarter and 2003. The company also intends to provide financial guidance for the coming year and an update on its product portfolio and manufacturing operations. Before the opening of trading on February 10, VaxGen plans to issue a press release containing financial results for the quarter and 12 months ended December 31, 2003. The press release will be followed by the call and webcast at noon, Eastern time, according to the company's standard disclosure procedure.
Market Data 
Markets 
AI
